Lupus Nephritis - Epidemiology Forecast to 2023; New Report Launched

DrugPipeline.net has announced the addition of “Lupus Nephritis - Epidemiology Forecast To 2023” research report to their website DrugPipeline.net

Logo

Bangalore, Karnataka -- (SBWire) -- 03/06/2017 --"Lupus Nephritis - Epidemiology Forecast To 2023" Report provides an overview of the disease and global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Lupus Nephritis from 2013-2023 for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan

Lupus Nephritis is the most common kidney disorder caused by the life-threatening autoimmune disease such as Systemic Lupus Erythematosus (SLE). It is a leading cause of morbidity and mortality in patients with Systemic Lupus Erythematosus. It leads to inflammation of small blood vessels which play an important role in filtering waste materials in kidney. It also involves the inflammation of glomeruli. It is observed that approximately 50% to 60% of adults and 30% to 80% of children with lupus develop Lupus Nephritis. Frequency of developing Lupus Nephritis decreases after 5 years of Systemic Lupus Erythematosus.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.

- The Report includes the Sex Specific and Age Specific Prevalence of Lupus Nephritis of 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan)

Spanning over 73 pages "Lupus Nephritis - Epidemiology Forecast To 2023" report covers Report Introduction, Lupus Nephritis: Overview, Unmet Needs, Epidemiology of Lupus Nephritis in 7MM, United States, Appendix, Report Methodology

For more information Visit at: http://www.drugpipeline.net/delveinsight/lupus-nephritis-epidemiology-forecast-2023

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Media Relations Contact

Sudeep Chakravarty
Director - Operations
DrugPipeline.net
http://www.drugpipeline.net/delveinsight/lupus-nephritis-epidemiology-forecast-2023

View this press release online at: http://rwire.com/778114